Race and medication adherence in Medicaid enrollees with type-2 diabetes

Rahul A Shenolikar, Rajesh Balkrishnan, Fabian T Camacho, J Timothy Whitmire, Roger T Anderson, Rahul A Shenolikar, Rajesh Balkrishnan, Fabian T Camacho, J Timothy Whitmire, Roger T Anderson

Abstract

Objective: The association of medication adherence with race has been inadequately studied previously in type-2 diabetes patients. The study objective was to determine the association between race and medication adherence among type-2 diabetes patients.

Methods: This was a retrospective cohort study, which compared medication adherence among different races of Medicaid insured patients with type-2 diabetes newly starting oral antidiabetic medication. A total of 1,527 African-American patients newly starting antidiabetic medication between July 2001 and June 2002 were compared with 1,128 white patients and 514 patients of other race. Medication adherence was measured as medication possession ratio using prescription refill patterns. Multivariate regression analyses were used to determine the difference in adherence rates adjusting for other covariates.

Results: Medication adherence rate was significantly higher for whites [0.59 (0.31)] as compared to African Americans [0.54 (0.31), (p<0.05)]. In multivariate analyses, the adherence rate of African-American patients was found to be significantly lower by 12% as compared to whites after adjusting for other covariates. Metformin users were associated with a 62% decrease in adherence rate as compared with the sulfonylureas group (p<0.05).

Conclusion: The antidiabetic medication adherence was associated with race. Future research should investigate patient-related factors affecting medication adherence in type-2 diabetes patients.

References

    1. Diabetes Care. 2003 Mar;26(3):917-32
    1. Ann Intern Med. 2002 Apr 16;136(8):565-74
    1. Am J Manag Care. 2004 Feb;10(2 Pt 2):144-51
    1. Diabetes Care. 2004 May;27(5):1218-24
    1. Ann Pharmacother. 2004 Sep;38(9):1357-62
    1. Curr Med Res Opin. 2004 Oct;20(10):1633-40
    1. Med Care. 1988 Aug;26(8):814-23
    1. J Clin Epidemiol. 1994 Jan;47(1):1-2
    1. Diabetes Care. 1997 Oct;20(10):1512-7
    1. Diabet Med. 1997;14 Suppl 5:S1-85
    1. Clin Ther. 1998 May-Jun;20(3):567-80
    1. Med Care. 1999 Sep;37(9):846-57
    1. Diabetes Educ. 2004 Jul-Aug;30(4):665-75
    1. J Natl Med Assoc. 2005 Jan;97(1):31-40
    1. Diabetes Educ. 2005 Mar-Apr;31(2):240-50
    1. J Natl Med Assoc. 2005 Apr;97(4):493-7
    1. Diabetes Care. 1999 Mar;22(3):403-8
    1. BMJ. 2000 Aug 12;321(7258):405-12
    1. JAMA. 2001 Jan 10;285(2):182-9
    1. Clin Ther. 2001 Aug;23(8):1311-20
    1. Diabetes Care. 2001 Oct;24(10):1821-33
    1. Diabet Med. 2002 Apr;19(4):279-84
    1. Clin Ther. 2003 Nov;25(11):2958-71

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe